2023. Advances in the pharmacotherapy of Heart Failure: type 2 sodium-glucose cotransporter Inhibitors (SGLT2) as a therapeutic option. Research, Society and Development. 12, 3 (Mar. 2023), e12412340502. DOI:https://doi.org/10.33448/rsd-v12i3.40502.